Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 42 studies | 35% ± 13% | |
capillary endothelial cell | 14 studies | 25% ± 7% | |
endothelial cell of lymphatic vessel | 13 studies | 32% ± 15% | |
endothelial cell of artery | 13 studies | 34% ± 11% | |
vein endothelial cell | 12 studies | 29% ± 18% | |
endothelial cell of vascular tree | 7 studies | 35% ± 20% | |
epithelial cell | 6 studies | 31% ± 10% | |
retinal rod cell | 5 studies | 23% ± 2% | |
oligodendrocyte | 5 studies | 27% ± 7% | |
retinal cone cell | 4 studies | 22% ± 2% | |
fibroblast | 4 studies | 29% ± 16% | |
lymphocyte | 4 studies | 21% ± 3% | |
macrophage | 4 studies | 23% ± 8% | |
type I pneumocyte | 4 studies | 21% ± 6% | |
pericyte | 4 studies | 23% ± 5% | |
smooth muscle cell | 4 studies | 19% ± 2% | |
GABAergic neuron | 4 studies | 21% ± 8% | |
astrocyte | 4 studies | 27% ± 10% | |
interneuron | 4 studies | 35% ± 21% | |
glomerular endothelial cell | 3 studies | 35% ± 2% | |
retinal pigment epithelial cell | 3 studies | 29% ± 12% | |
adipocyte | 3 studies | 17% ± 2% | |
endocardial cell | 3 studies | 30% ± 9% | |
endothelial cell of sinusoid | 3 studies | 31% ± 17% | |
hepatocyte | 3 studies | 34% ± 17% | |
goblet cell | 3 studies | 31% ± 7% | |
enteroendocrine cell | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2468.53 | 1445 / 1445 | 100% | 18.31 | 183 / 183 |
prostate | 100% | 2972.20 | 245 / 245 | 100% | 20.86 | 502 / 502 |
breast | 100% | 5830.12 | 459 / 459 | 100% | 18.84 | 1116 / 1118 |
intestine | 100% | 2681.39 | 966 / 966 | 100% | 15.05 | 525 / 527 |
thymus | 100% | 3993.38 | 653 / 653 | 100% | 21.51 | 602 / 605 |
lung | 100% | 4246.67 | 578 / 578 | 99% | 15.00 | 1149 / 1155 |
ovary | 100% | 3042.46 | 180 / 180 | 99% | 15.70 | 427 / 430 |
bladder | 100% | 2677.62 | 21 / 21 | 99% | 12.76 | 500 / 504 |
kidney | 100% | 2408.87 | 89 / 89 | 99% | 20.21 | 893 / 901 |
stomach | 100% | 1791.58 | 359 / 359 | 99% | 16.54 | 283 / 286 |
pancreas | 100% | 1940.11 | 328 / 328 | 99% | 16.58 | 176 / 178 |
uterus | 100% | 3892.07 | 170 / 170 | 99% | 13.25 | 453 / 459 |
skin | 100% | 2862.08 | 1808 / 1809 | 99% | 20.43 | 465 / 472 |
brain | 99% | 1856.33 | 2606 / 2642 | 100% | 19.63 | 703 / 705 |
adrenal gland | 100% | 1802.16 | 258 / 258 | 97% | 16.84 | 223 / 230 |
liver | 98% | 1274.17 | 222 / 226 | 89% | 8.05 | 361 / 406 |
adipose | 100% | 6027.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3934.97 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2886.06 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4157.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.38 | 1 / 1 |
heart | 100% | 2289.63 | 860 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 7.90 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 88% | 7.38 | 70 / 80 |
peripheral blood | 47% | 644.65 | 434 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016601 | Biological process | Rac protein signal transduction |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_1905762 | Molecular function | CCR4-NOT complex binding |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | GARRE1 |
Protein name | KIAA0355 protein Granule associated Rac and RHOG effector protein 1 (GARRE1) Granule-associated Rac and RHOG effector protein 1 Granule associated Rac and RHOG effector 1 Granule associated Rac and RHOG effector 1 (Granule-associated Rac and RHOG effector protein 1) |
Synonyms | KIAA0355 |
Description | FUNCTION: Acts as an effector of RAC1 . Associates with CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation . May also play a role in miRNA silencing machinery . . |
Accessions | A0A0G2JQ76 ENST00000299505.8 A0A0J9YXL1 A0A0G2JQ84 U3KPV0 O15063 K7EPA0 ENST00000588470.5 ENST00000589583.5 ENST00000625057.1 ENST00000623152.1 ENST00000634164.1 A1A512 ENST00000623194.3 |